These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2506297)

  • 21. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
    Kurane I; Takasaki T
    Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
    Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
    Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area.
    Wills MR; Sil BK; Cao JX; Yu YX; Barrett AD
    Vaccine; 1992; 10(12):861-72. PubMed ID: 1455912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses.
    Higgs S; Gould EA
    Arch Virol; 1991; 119(1-2):119-33. PubMed ID: 1650549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of experimental live attenuated Japanese encephalitis vaccine viruses and comparison with wild-type strains using monoclonal and polyclonal antibodies.
    Sil BK; Wills MR; Cao JX; Sharda R; Islam MA; Stagg DJ; Jennings AD; Gibson CA; Barrett AD
    Vaccine; 1992; 10(5):329-33. PubMed ID: 1315470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunogenicity and stability of a Soviet inactivated cultured vaccine against Japanese encephalitis].
    Khanina MK; Bochkova NG; Grachev VP; El'bert LB; Vorob'eva MS; Borsuk EA; Pogodina VV
    Vopr Virusol; 1990; 35(6):478-80. PubMed ID: 2082551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016.
    Maeki T; Tajima S; Kyaw AK; Matsumoto F; Miura K; Yamashita A; Yoshikawa A; Negishi K; Noguchi Y; Tadokoro K; Abe K; Taruya J; Koh J; Ito H; Ikegaya A; Abe F; Wada M; Nishigata T; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Morita K; Lim CK; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):360-364. PubMed ID: 29962489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of virus specific epitopes on JE virus 'E' glycoprotein by acetone treatment.
    Gupta AK; Lad VJ; Koshy AA; Ayachit VM; Gadkari DA
    Indian J Med Res; 2000 Oct; 112():113-20. PubMed ID: 11200676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization antibody responses induced by Japanese encephalitis virus vaccine.
    Susilowati S; Okuno Y; Fukunaga T; Tadano M; Juang RF; Fukai K
    Biken J; 1981 Dec; 24(4):137-45. PubMed ID: 7346039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic and genetic analysis of Japanese encephalitis viruses isolated from Korea.
    Chung YJ; Nam JH; Ban SJ; Cho HW
    Am J Trop Med Hyg; 1996 Jul; 55(1):91-7. PubMed ID: 8702029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope mapping of Japanese encephalitis virus envelope protein using monoclonal antibodies against an Indian strain.
    Cecilia D; Gadkari DA; Kedarnath N; Ghosh SN
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2741-7. PubMed ID: 2460583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of neutralizing antibodies to Japanese encephalitis virus by enzyme-linked immunosorbent assay (ELISA)].
    Chow L; Yueh YY; Tseng WL; Wu YC; Wu SC; Horng CB
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Nov; 30(4):255-64. PubMed ID: 10592829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in dengue and Japanese encephalitis (JE) antibody after JE vaccination.
    Quina MA; Thein S; Auvanich W; Okuno Y; Igarashi A; Fukai K
    Biken J; 1978 Dec; 21(4):149-59. PubMed ID: 754688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and characterization of Japanese encephalitis virus specific monoclonal antibodies.
    Ma SH; Lin YL; Huang YY; Liu CI; Chen SS; Chiang HY; Chen LK
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1995 May; 28(2):128-38. PubMed ID: 9774991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.
    Cao JX; Ni H; Wills MR; Campbell GA; Sil BK; Ryman KD; Kitchen I; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2757-64. PubMed ID: 7595383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.